135 related articles for article (PubMed ID: 22944296)
1. Epithelial and cartilaginous differentiation in clear cell chondrosarcoma.
Matsuura S; Ishii T; Endo M; Takahashi Y; Setsu N; Yamamoto H; Tamiya S; Iwamoto Y; Oda Y
Hum Pathol; 2013 Feb; 44(2):237-43. PubMed ID: 22944296
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.
Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A
Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163
[TBL] [Abstract][Full Text] [Related]
3. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
[TBL] [Abstract][Full Text] [Related]
4. Clear cell chondrosarcoma: a pathological and immunohistochemical study.
Masui F; Ushigome S; Fujii K
Histopathology; 1999 May; 34(5):447-52. PubMed ID: 10231420
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
6. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
8. Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line.
Tang X; Lu X; Guo W; Ren T; Zhao H; Zhao F; Tang G
Eur J Cancer Prev; 2010 Nov; 19(6):466-71. PubMed ID: 20683191
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study on clear cell chondrosarcoma].
Wang LT
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):306-8. PubMed ID: 1806353
[TBL] [Abstract][Full Text] [Related]
10. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
[TBL] [Abstract][Full Text] [Related]
12. Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases.
Sung MT; Maclennan GT; Lopez-Beltran A; Zhang S; Montironi R; Cheng L
Am J Surg Pathol; 2008 Jan; 32(1):146-55. PubMed ID: 18162782
[TBL] [Abstract][Full Text] [Related]
13. Clear cell chondrosarcoma of bone. A report of three cases with immunohistochemical and affinity histochemical observations.
Wang LT; Liu TC
Pathol Res Pract; 1993 May; 189(4):411-5. PubMed ID: 8351242
[TBL] [Abstract][Full Text] [Related]
14. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
15. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
Akpalo H; Lange C; Zustin J
Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
[TBL] [Abstract][Full Text] [Related]
16. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin-, calponin-, and p63-positive chondroblastoma with extensive soft tissue involvement and vascular invasion: a potential diagnostic dilemma.
Ho YH; Cheng MH; Yap WM; Chuah KL
Ann Diagn Pathol; 2011 Feb; 15(1):58-63. PubMed ID: 20952302
[No Abstract] [Full Text] [Related]
18. The diagnostic value of cytokeratins expression in the renal parenchyma tumors.
Alexa A; Baderca F; Lighezan R; Izvernariu D; Raica M
Rom J Morphol Embryol; 2010; 51(1):27-35. PubMed ID: 20191116
[TBL] [Abstract][Full Text] [Related]
19. Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation.
Kaim AH; Hügli R; Bonél HM; Jundt G
Skeletal Radiol; 2002 Feb; 31(2):88-95. PubMed ID: 11828329
[TBL] [Abstract][Full Text] [Related]
20. Chondromyxoid fibroma: report of six cases with immunohistochemical studies.
Bleiweiss IJ; Klein MJ
Mod Pathol; 1990 Nov; 3(6):664-6. PubMed ID: 2263591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
